Centre for Human Drug Research

• THC for chronic neuropathic pain Recruiting
  2022-502343-35-00 Phase II 1 country DRONABINOL
• Research into the effects of the drug DMT in healthy volunteers Halted
  2025-521605-40-00 Phase I (Other) 1 country
• Research into new test methods to measure pain with two existing drugs (nefopam and oxycodone) Ended
  2025-522389-66-00 Phase I (Other) 1 country
• Measuring the macro- and microvascular responses to LPS and exenatide Ended
  2024-519014-31-00 Phase I (Other) 1 country
• Intradermal LPS to study vascular responses Ended
  2024-512377-27-00 Phase I (Other) 1 country
• A Randomized, double-blind, placebo-controlled, three-way cross-over study to assess the pharmacodynamic effects of an authorised and a new … Ended
  2024-510721-26-00 Phase I (Other) 1 country
• CBD, amitriptyline and tramadol drug-drug interaction study Ended
  2023-508428-36-00 Phase II 1 country
• Imatinib PD in healthy subjects Ended
  2023-504958-35-00 Phase I (Other) 1 country
• Study to assess the effects of oral cannabidiol in healthy male subjects on CNS using the NeuroCart test battery and TMS. Ended
  2023-508311-23-00 Phase II 1 country CANNABIDIOL
• A randomized, double-blind, double dummy, placebo-controlled, four-way cross-over study to investigate the analgesic effects and CNS effects… Ended
  2023-505793-15-00 Phase I (Other) 1 country
• Monitoring the AD effects of ketamine in MDD patients Ended
  2024-510891-20-00 Phase I (Other) 1 country

Showing 1–11 of 11 trials